BioSpace News Archive

AllerGenis announced the publication of a peer-reviewed study entitled, “Accurate and Reproducible Diagnosis of Peanut Allergy Using Epitope Mapping.” Conducted by leading global experts in pediatric allergy and immunology from the Icahn School of Medicine at Mount Sinai, Stanford University and Kings College, the study found the AllerGenis peanut diagnostic blood test demonstrates accuracy significantly and statistically superior to all other established diagnostic tests.

Silverback Therapeutics, Inc. today announced that the Company will participate in the Raymond James Human Health Innovation Conference.

Ashvattha Therapeutics today announced positive interim results from its ongoing multicenter Phase 2 PRANA clinical study of the HDT, OP-101, to treat hyperinflammation in hospitalized adults with severe COVID-19.

Nascent Biotech, Inc. is pleased to highlight the publication of an in-depth analyst research report on Nascent Biotech by equity research firm, Marble Arch Research, Inc.

Echelon Diagnostics, Inc., a leading provider of genomic healthcare AI imaging and big data solutions, today announced a strategic collaboration with Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum

CURE Pharmaceutical Holding Corp. announced today that its Chief Business Officer Jonathan Berlent will participate in a virtual presentation at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on Thursday, June 17.

NanoDx, Inc. announced that it has formed a partnership with the Home Base Program to increase the awareness of the long-term issues associated with TBI in both active and retired military personnel.

IMMUNOPRECISE ANTIBODIES LTD will be presented in partnering meetings at the 2021 BIO International Convention, June 14-18, 2021.

Polydex Pharmaceuticals Limited reports financial results for the first quarter of fiscal 2022, the period ended April 30, 2021.

With an estimated 6 million people worldwide living with Parkinson’s, and an estimated 60,000 newly diagnosed annually, resources to help navigate available treatments to manage Parkinson’s care are critical.